Connacht Asset Management’s Guardant Health GH Stock Holding History

Connacht Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,048	Closed	-$328K	–	141
2022 Q4	$328K	Buy	12,048 +4,883	+68%	+$223K	0.15%	88
2022 Q3	$386K	Buy	7,165 +474	+7%	+$24.3K	0.27%	86
2022 Q2	$270K	Buy	+6,691	New	+$332K	0.11%	127
2021 Q1	–	Sell	-12,976	Closed	-$1.67M	–	136
2020 Q4	$1.67M	Buy	+12,976	New	+$1.49M	0.79%	45

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Connacht Asset Management's GH Position: Q1 2023 in Review

Connacht Asset Management sold out of Guardant Health (GH) in Q1 2023, closing a stake of 12,048 shares — an estimated $328K sold.

Connacht Asset Management first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $1.67M in Q4 2020. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

Connacht Asset Management reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
Connacht Asset Management sold 12,048 Guardant Health shares in Q1 2023, an estimated $328K.
Connacht Asset Management first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
Connacht Asset Management's Guardant Health position peaked at $1.67M in Q4 2020.
279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Connacht Asset Management's 13F filing for Q1 2023, filed 15 May 2023.